Media Coverage header image

Media Coverage

Advanced Search
  • 09272018
    360Dx

    Quest Diagnostics announced today it has acquired specialized anatomic pathology service firm PhenoPath. The deal, whose terms were not disclosed, continued a buying spree for Quest this week, which included the acquisitions of Oxford Immunotec's US lab business and fertility and fertility diagnostics services firm ReproSource. PhenoPath is based in Seattle and provides anatomic pathology, molecular oncology, and other services such as genetic sequencing and genomic tumor analysis. It will operate as part of AmeriPath, a wholly owned subsidiary of Quest.

  • 09262018
    Decatur Daily Democrat

    Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide supply chain expertise, as well as perform laboratory reference testing.

  • 09252018
    CBS News Online

    Since Colorado legalized marijuana, the state has become a popular destination for so-called weed tourists. Johnny Welsh, a writer and bartender in Frisco, Colorado, a Rocky Mountain town near Vail, remembers when he would have the entire fall off work. "The restaurants closed, and you could travel the world," he told MoneyWatch, somewhat wistfully. Nationwide, the rate of workers testing positive for drugs has increased over the past decade, according to Quest Diagnostics, a major drug-testing laboratory. It has also risen in states that have made the drug legal. But the rate of increase has been about the same across the two categories, said Barry Sample, Quest's senior director for science and technology.

  • 09242018
    360Dx

    Quest Diagnostics today announced it has acquired fertility diagnostics service firm ReproSource for an undisclosed amount. Based Woburn, Massachusetts, ReproSource provides services such as ovarian health and recurrent pregnancy loss assessments, as well as implantation failure and semen quality. According to the company's website, it purchased the assets of "the largest fertility-focused laboratory in the United States" in 2008, and since then it improved and expanded its core services while establishing partnerships with laboratory, academic, and industry players in the US and globally.

  • 09202018
    Detroit Free Press

    If voters decide in November to legalize marijuana for recreational use, pot-smoking job seekers and employees beware. Legalization will not protect job applicants or employees who test positive for marijuana use on pre-employment drug tests or random workplace drug testing. Yes, you can still get fired or not be hired for a positive test. Unlike alcohol, where Breathalyzer tests can show the exact level in a person’s blood, there are few available tests that show the level of impairment for marijuana. Saliva swabs and urine samples only show if THC, the psychoactive component in marijuana, has been used over the last few days, said Dr. Barry Sample, of Quest Diagnostics, a New Jersey company that analyzes millions of workplace drug tests every year, not a person’s level of impairment at the time of a test. Tests of hair samples will show THC levels going back as long as 90 days.